Literature DB >> 30457979

Spec-seq unveils transcriptional subpopulations of antibody-secreting cells following influenza vaccination.

Karlynn E Neu1,2, Jenna J Guthmiller2, Min Huang2, Jennifer La3, Marcos C Vieira4, Kangchon Kim4, Nai-Ying Zheng2, Mario Cortese5, Micah E Tepora1, Natalie J Hamel1, Karla Thatcher Rojas2, Carole Henry2, Dustin Shaw1,2, Charles L Dulberger6, Bali Pulendran5, Sarah Cobey4, Aly A Khan7, Patrick C Wilson1,2.   

Abstract

Vaccines are among the most effective public health tools for combating certain infectious diseases such as influenza. The role of the humoral immune system in vaccine-induced protection is widely appreciated; however, our understanding of how antibody specificities relate to B cell function remains limited due to the complexity of polyclonal antibody responses. To address this, we developed the Spec-seq framework, which allows for simultaneous monoclonal antibody (mAb) characterization and transcriptional profiling from the same single cell. Here, we present the first application of the Spec-seq framework, which we applied to human plasmablasts after influenza vaccination in order to characterize transcriptional differences governed by B cell receptor (BCR) isotype and vaccine reactivity. Our analysis did not find evidence of long-term transcriptional specialization between plasmablasts of different isotypes. However, we did find enhanced transcriptional similarity between clonally related B cells, as well as distinct transcriptional signatures ascribed by BCR vaccine recognition. These data suggest IgG and IgA vaccine-positive plasmablasts are largely similar, whereas IgA vaccine-negative cells appear to be transcriptionally distinct from conventional, terminally differentiated, antigen-induced peripheral blood plasmablasts.

Entities:  

Keywords:  Adaptive immunity; B cells; Immunology; Influenza; Vaccines

Mesh:

Substances:

Year:  2018        PMID: 30457979      PMCID: PMC6307935          DOI: 10.1172/JCI121341

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

1.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias.

Authors:  B M Bolstad; R A Irizarry; M Astrand; T P Speed
Journal:  Bioinformatics       Date:  2003-01-22       Impact factor: 6.937

2.  Full-length RNA-seq from single cells using Smart-seq2.

Authors:  Simone Picelli; Omid R Faridani; Asa K Björklund; Gösta Winberg; Sven Sagasser; Rickard Sandberg
Journal:  Nat Protoc       Date:  2014-01-02       Impact factor: 13.491

3.  Blood-borne human plasma cells in steady state are derived from mucosal immune responses.

Authors:  Henrik E Mei; Taketoshi Yoshida; Wondossen Sime; Falk Hiepe; Kathi Thiele; Rudolf A Manz; Andreas Radbruch; Thomas Dörner
Journal:  Blood       Date:  2008-11-05       Impact factor: 22.113

4.  Analysis of IgA1 N-glycosylation and its contribution to FcalphaRI binding.

Authors:  Michelle M Gomes; Stephanie B Wall; Kazuo Takahashi; Jan Novak; Matthew B Renfrow; Andrew B Herr
Journal:  Biochemistry       Date:  2008-10-01       Impact factor: 3.162

Review 5.  The human intestinal B-cell response.

Authors:  J Spencer; L M Sollid
Journal:  Mucosal Immunol       Date:  2016-07-27       Impact factor: 7.313

6.  Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen.

Authors:  Kenneth Smith; Lori Garman; Jens Wrammert; Nai-Ying Zheng; J Donald Capra; Rafi Ahmed; Patrick C Wilson
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

7.  MACSE: Multiple Alignment of Coding SEquences accounting for frameshifts and stop codons.

Authors:  Vincent Ranwez; Sébastien Harispe; Frédéric Delsuc; Emmanuel J P Douzery
Journal:  PLoS One       Date:  2011-09-16       Impact factor: 3.240

8.  Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination.

Authors:  Maurice H J Selman; Sanne E de Jong; Darius Soonawala; Frank P Kroon; Ayola Akim Adegnika; André M Deelder; Cornelis H Hokke; Maria Yazdanbakhsh; Manfred Wuhrer
Journal:  Mol Cell Proteomics       Date:  2011-12-19       Impact factor: 5.911

9.  Fast and accurate single-cell RNA-seq analysis by clustering of transcript-compatibility counts.

Authors:  Vasilis Ntranos; Govinda M Kamath; Jesse M Zhang; Lior Pachter; David N Tse
Journal:  Genome Biol       Date:  2016-05-26       Impact factor: 13.583

Review 10.  Tools to therapeutically harness the human antibody response.

Authors:  Patrick C Wilson; Sarah F Andrews
Journal:  Nat Rev Immunol       Date:  2012-10       Impact factor: 53.106

View more
  19 in total

1.  Differential transcriptome and development of human peripheral plasma cell subsets.

Authors:  Swetha Garimalla; Doan C Nguyen; Jessica L Halliley; Christopher Tipton; Alexander F Rosenberg; Christopher F Fucile; Celia L Saney; Shuya Kyu; Denise Kaminski; Yu Qian; Richard H Scheuermann; Greg Gibson; Iñaki Sanz; F Eun-Hyung Lee
Journal:  JCI Insight       Date:  2019-05-02

2.  Benchmarking computational methods for B-cell receptor reconstruction from single-cell RNA-seq data.

Authors:  Tommaso Andreani; Linda M Slot; Samuel Gabillard; Carsten Strübing; Claus Reimertz; Veeranagouda Yaligara; Aleida M Bakker; Reza Olfati-Saber; René E M Toes; Hans U Scherer; Franck Augé; Deimantė Šimaitė
Journal:  NAR Genom Bioinform       Date:  2022-07-13

3.  Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopes.

Authors:  Alec W Freyn; Julianna Han; Jenna J Guthmiller; Mark J Bailey; Karlynn Neu; Hannah L Turner; Victoria C Rosado; Veronika Chromikova; Min Huang; Shirin Strohmeier; Sean T H Liu; Viviana Simon; Florian Krammer; Andrew B Ward; Peter Palese; Patrick C Wilson; Raffael Nachbagauer
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-23       Impact factor: 11.205

4.  IgA Responses Following Recurrent Influenza Virus Vaccination.

Authors:  Rodrigo B Abreu; Emily F Clutter; Sara Attari; Giuseppe A Sautto; Ted M Ross
Journal:  Front Immunol       Date:  2020-05-19       Impact factor: 7.561

Review 5.  Can We Improve Vaccine Efficacy by Targeting T and B Cell Repertoire Convergence?

Authors:  Katja Fink
Journal:  Front Immunol       Date:  2019-02-13       Impact factor: 7.561

6.  Massively parallel single-cell B-cell receptor sequencing enables rapid discovery of diverse antigen-reactive antibodies.

Authors:  Leonard D Goldstein; Ying-Jiun J Chen; Jia Wu; Subhra Chaudhuri; Yi-Chun Hsiao; Kellen Schneider; Kam Hon Hoi; Zhonghua Lin; Steve Guerrero; Bijay S Jaiswal; Jeremy Stinson; Aju Antony; Kanika Bajaj Pahuja; Dhaya Seshasayee; Zora Modrusan; Isidro Hötzel; Somasekar Seshagiri
Journal:  Commun Biol       Date:  2019-08-09

Review 7.  Remembrance of Things Past: Long-Term B Cell Memory After Infection and Vaccination.

Authors:  Anna-Karin E Palm; Carole Henry
Journal:  Front Immunol       Date:  2019-07-31       Impact factor: 7.561

8.  A (class-)switch in the antibody response may distinguish primary from secondary dengue virus infection.

Authors:  Lisa Levoir; Leslie Goo
Journal:  EBioMedicine       Date:  2020-05-23       Impact factor: 8.143

9.  Single-cell BCR and transcriptome analysis after influenza infection reveals spatiotemporal dynamics of antigen-specific B cells.

Authors:  Nimitha R Mathew; Jayalal K Jayanthan; Ilya V Smirnov; Jonathan L Robinson; Hannes Axelsson; Sravya S Nakka; Aikaterini Emmanouilidi; Paulo Czarnewski; William T Yewdell; Karin Schön; Cristina Lebrero-Fernández; Valentina Bernasconi; William Rodin; Ali M Harandi; Nils Lycke; Nicholas Borcherding; Jonathan W Yewdell; Victor Greiff; Mats Bemark; Davide Angeletti
Journal:  Cell Rep       Date:  2021-06-22       Impact factor: 9.995

10.  An Egg-Derived Sulfated N-Acetyllactosamine Glycan Is an Antigenic Decoy of Influenza Virus Vaccines.

Authors:  Jenna J Guthmiller; Henry A Utset; Carole Henry; Lei Li; Nai-Ying Zheng; Weina Sun; Marcos Costa Vieira; Seth Zost; Min Huang; Scott E Hensley; Sarah Cobey; Peter Palese; Patrick C Wilson
Journal:  mBio       Date:  2021-06-15       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.